Bipolar Mood Disorder: Practical Strategies for Acute and Maintenance Phase Treatment

Journal of Clinical Psychopharmacology

Volumn 16, Issue 2 SUPPL. 1, 1996, Pages

  Sachs, Gary S ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CARBAMAZEPINE; CLONAZEPAM; CLOZAPINE; LITHIUM; RISPERIDONE; VALPROATE SEMISODIUM;

BIPOLAR DEPRESSION; ELECTROCONVULSIVE THERAPY; HUMAN; MANIC DEPRESSIVE PSYCHOSIS; MOOD; PRIORITY JOURNAL; PSYCHOTHERAPY; REVIEW;

ACUTE DISEASE; ADULT; ANTICONVULSANTS; ANTIMANIC AGENTS; BIPOLAR DISORDER; CARBAMAZEPINE; CLINICAL TRIALS; COMBINED MODALITY THERAPY; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INFANT, NEWBORN; LONG-TERM CARE; MALE; PREGNANCY; PSYCHOTROPIC DRUGS; TREATMENT OUTCOME; VALPROIC ACID;

EID: 0030010429     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-199604001-00005     Document Type: Article

References (87)

1. Wehr TA, Goodwin FK. Can antidepressants cause mania and worsen the course of affective illness? Am J Psychiatry 1987;144:1403-11.
2. Kukopulos A, Reginaldi D, Laddomada P, Floric G, Serra G, Tondo L. Course of the manic-depressive cycle and changes caused by treatment. Pharmacopsychiatry 1980;13:156-67.
3. Esparon J, Kolloori J, Naylor GJ, McHarg AM, Smith AHW, Hopwood SE. Comparison of the prophylactic action of flupenthixol with placebo in lithium treated manic-depressive patients. Br J Psychiatry 1986;148:723-5.
4. Goodwin FK, Murphy DL, Bunney WF Jr. Lithium carbonate treatment in depression and mania: a longitudinal double-blind study. Arch Gen Psychiatry 1969;21:486-96.
5. Maggs R. Treatment of manic illness with lithium carbonate. Br J Psychiatry 1963;109:56-65.
6. Schou M, Juel-Nielsen N, Strömgren E, Voldby H. The treatment of manic psychoses by the administration of lithium salts. J Neurol Neurosurg Psychiatry 1954;17:250-60.
7. Stokes PE, Shamoian CA, Stoll PM, Patton MJ. Efficacy of lithium as acute treatment of manic-depressive illness. Lancet 1971;1:1319-25.
8. Mendels J, Secunda SK, Dyson WL. A controlled study of the antidepressant effects of lithium carbonate. Arch Gen Psychiatry 1972;26:154-7.
9. Watanabe S, Ishino H, Otsuki S. Double-blind comparison of lithium carbonate and imipramine in treatment of depression. Arch Gen Psychiatry 1975;32:659-68.
10. Kahn MC. Lithium carbonate in the treatment of acute depressive illness. Bibl Psychiatr 1981;161:244-8.
11. Baastrup PC, Poulsen JC, Schou M, Thomsen K, Amdisen A. Prophylactic lithium: double blind discontinuation in manic-depressive and recurrent-depressive disorders. Lancet 1970;2:326-30.
12. Melia PI. Prophylactic lithium: a double-blind trial in recurrent affective disorders. Br J Psychiatry 1970;116:621-4.
13. Goodwin FK, Jamison KR. Maintenance medical treatment. In: Goodwin FK, Jamison KR, eds. Manic-depressive illness. New York: Oxford University Press, 1990:665-724.
14. Wehr TA, Sack DA, Rosenthal NE, Cowdry RW. Rapid cycling affective disorder: contributing factors and treatment responses in 51 patients. Am J Psychiatry 1988;145:179-84.
15. Mayo JA, O'Connell RA, O'Brien JD. Families of manic-depressive patients: effect of treatment. Am J Psychiatry 1979;136:1525-9.
16. Lesser AL. Hypomania and marital conflict. Can J Psychiatry 1983;28:362-6.
17. Vasile RG, Samson JA, Bemporad J, Bloomingdale KL, Creasey D, Fenton BJ, Gudeman JE, Schildkraut JJ. A biopsychosocial approach to treating patients with affective disorders. Am J Psychiatry 1987;144:341-4.
18. Miklowitz DL, Goldstein MJ, Nuechterlein KH, Snyder KS, Mintz J. Family factors and the course of bipolar affective disorder. Arch Gen Psychiatry 1988;45:225-31.
19. Van Gent EM, Vida SL, Zwart FM. Group therapy in addition to lithium therapy in patients with bipolar disorders. Acta Psychiatr Belg 1988;88:405-18.
20. Kanas N. Group psychotherapy with bipolar patients: a review and synthesis. Int J Group Psychother 1993;43:321-33.
21. Post RM, Kramlinger KG. Treatment of rapid cycling bipolar illness. Biol Res 1990;26:37-47.
22. Biederman J, Lerner Y, Belmaker RH. Combination of lithium carbonate and haloperidol in schizo-affective disorder. Arch Gen Psychiatry 1979;36:327-33.
23. Kupfer D, Frank E, Perel JM, Cornes C, Mallinger AG, Thase ME, McEachran AB, Grochocinski VJ. Five-year outcome for maintenance therapies in recurrent depression. Arch Gen Psychiatry 1992;49:769-73.
24. Keller MB, Lavori PW, Kane JM, Gelenberg AJ, Rosenbaum JF, Walzer EA, Baker LA. Subsyndromal symptoms in bipolar disorder: a comparison of standard and low serum levels of lithium. Arch Gen Psychiatry 1992;49:371-6.
25. Fava GA. Prodromal symptoms in affective disorders. Am J Psychiatry 1991;148:823-30.
26. Prien RF, Klett CJ, Caffey EM. Lithium carbonate and imipramine in prevention of affective episodes: a comparison in recurrent affective illness. Arch Gen Psychiatry 1973;29:420-5.
27. Quitkin FM, Kane J, Rifkin A, Ramos-Lorenzi JR, Nayak V. Prophylactic lithium carbonate with and without imipramine for bipolar I patients. Arch Gen Psychiatry 1981;38:902-7.
28. Fieve RR, Platman SR, Plutchik RR. The use of lithium in affective disorders I: acute endogenous depression. Am J Psychiatry 1968;125:487-91.
29. Baastrup PC, Poulsen JC, Schou M, Thomsen K, Amdisen A. Prophylactic lithium: double-blind discontinuation in manic-depressive and recurrent-depressive disorders. Lancet 1970;2:326-30.
30. Coppen A, Noguera R, Bailey J, Burns BH, Swani MS, Hare EH, Gardner R, Maggs R. Prophylactic lithium in affective disorders: collective trial. Lancet 1971;2:275-9.
31. Cundall RL, Brooks PW, Murray LG. A controlled evaluation of lithium prophylaxis in affective disorders. Psychol Med 1972;2:308-11.
32. Stallone F, Shelley E, Mendlewicz J, Fieve RR. The use of lithium in affective disorders, III: a double-blind study of prophylaxis in bipolar illness. Am J Psychiatry 1973;130:1006-10.
33. Fieve RR, Kumbaraci T, Dunner DL. Lithium prophylaxis of depression in bipolar I, bipolar II, and unipolar patients. Am J Psychiatry 1976;133:925-9.
34. Dunner DL, Stallone F, Fieve RR. Lithium carbonate and affective disorders. Arch Gen Psychiatry 1976;33:117.
35. Quitkin F, Rifkin A, Kane J, Ramos-Lorenzi JR, Klein DF. Prophylactic effect of lithium and imipramine in unipolar and bipolar II patients: a preliminary report. Am J Psychiatry 1978;135:570-2.
36. Thibault A, Sachs GS, Lafer B, Kokokletsky J, Rosenbaum J. Bipolar relapse rates during maintenance therapy [abstr]. 146th Annual Meeting of the American Psychiatric Association, San Francisco, 1993.
37. Jann MW, Bitar AH, Rao A. Lithium prophylaxis of tricyclic-antidepressant-induced mania in bipolar patients. Am J Psychiatry 1982;139:683-4.
38. Price LH, Charney DS, Heninger GR. Manic symptoms following addition of lithium to antidepressant treatment. J Clin Psychopharmacol 1984;4:361-2.
39. Kishimoto A, Kamata K, Sugihara T, Ishiguro S, Hazama H, Mizukawa R, Kunimoto N. Treatment of depression with clonazepam. Acta Psychiatr Scand 1988;77:81-6.
40. Rush AJ, Schlesser MA, Erman M, Fairchild C. Alprazolam in bipolar depression. Pharmacotherapy 1984;4:40-2.
41. Zomberg GL, Pope HG Jr. Treatment of depression in bipolar disorder. new directions for research. J Clin Psychopharmacol 1993;13:397-408.
42. Conn JB, Collins G, Ashbrook E, Wernicke JF. A comparison of fluoxetine, imipramine, and placebo in patients with bipolar depressive disorder. Int Clin Psychopharmacol 1989;4:313-22.
43. Himmelhoch JM, Thase ME, Mallinger AG, Houck P. Tranylcypromine vs. imipramine in anergic bipolar depression. Am J Psychiatry 1991;148:910-6.
44. Sachs GS, Lafer B, Stoll AL, Banov M, Thibault AB, Tohen M, Rosenbaum JF. A double-blind trial of bupropion versus desipramine for bipolar depression. J Clin Psychiatry 1994;55:391-3.
45. Baumhackl U, Biziere K, Fischback R, Geretstegger CH, Hebenstreit G, Radmayr E, Stabl M. Efficacy and tolerability of moclobemide compared with imipramine in depressive disorder (DSM III): an Austrian double-blind, multicentre study. Br J Psychiatry 1989;155:78-83.
46. Fabre LF, Brodie KH, Garver D, Zung WK. A multicenter evaluation of bupropion versus placebo in hospitalized depressed patients. J Clin Psychiatry 1983;44:88-94.
47. Kessell A, Holt NF. A controlled study of a tetracyclic antidepressant-maprotiline (Ludiomil). Med J Aust 1975;1:773-6.
48. Meredith CH, Feighner JP. The use of bupropion in hospitalized depressed patients. J Clin Psychiatry 1983;44:85-7.
49. Goodwin FK, Jamison KR. Manic-depressive illness. New York: Oxford University Press, 1990.
50. Peet M. Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants. Br J Psychiatry 1994;164:549-50.
51. Altshuler LL, Post RM, Leverich GS, Mikalauskas K, Rosoff A, Ackerman BA. Antidepressant-induced mania and cycle acceleration: a controversy revisited. Am J Psychiatry 1995;152:1130-8.
52. Stoll AL, Mayer PV, Kolbrener M, Goldstein E, Suplit B, Lucier J, Cohen BM, Tohen M. Antidepressant-associated mania: a controlled comparison with spontaneous mania. Am J Psychiatry 1994;151:1642-5.
53. Small JG, Small IF, Milstein V, Kellams JJ, Mapper MH. Manic symptoms: an indication for bilateral ECT. Biol Psychiatry 1985;20:125-34.
54. Maj M, Pirozzi R, Starace F. Previous pattern of course of the illness as a predictor of response to lithium prophylaxis in bipolar patients. J Affect Disord 1989;17:237-41.
55. Dunner DL. Rapid cycling bipolar manic depressive illness. Psychiatr Clin North Am 1979;2:461-7.
56. Keller MB, Lavori PW, Coryell W, Andreasen NC, Endicott J, Clayton PJ, Klerman GL, Hirschfeld RMA. Differential outcome of pure manic, mixed/cycling, and pure depressive episodes in patients with bipolar illness. JAMA 1986;255:3138-42.
57. Dilsaver SC, Swann AC, Shoaib AM. The manic syndrome: factors which may predict a patient's response to lithium, carbamazepine and valproate. J Psychiatry Neurosci 1993;18:61-6.
58. Bowden CL, Brugger AM, Swann AC, Calabrese JR, Janicak PG, Petty F, Dilsaver SC, Davis JM, Rush AJ, Small JG, Garza-Trevino ES, Risch SC, Goodnick PJ, Morris DD, for the Depakote Mania Study Group. Efficacy of divalproex vs lithium, placebo in the treatment of mania. JAMA 1994;271:918-24.
59. Prien RF, Himmelhoch JM, Kupfer DJ. Treatment of mixed mania. J Affect Disord 1988;15:9-15.
60. Post RM, Rubinow DR, Uhde TW, Roy-Byrne PP, Linnoila M, Rosoff A, Cowdry R. Dysphoric mania: clinical and biological correlates. Arch Gen Psychiatry 1989;46:353-8.
61. Dilsaver SC, Swann AC, Shoaib AM, Bowers TC, Halle MT. Depressive mania associated with nonresponse to antimanic agents. Am J Psychiatry 1993;150:1548-51.
62. Brown ES, Dilsaver SC, Swann AC. Depressive mania: response of residual depression to bupropion. Biol Psychiatry 1994;35:493-4.
63. Suppes T, Baldessarini RJ, Faedda GL, Tohen M. Risk of recurrence following discontinuation of lithium treatment of bipolar disorder. Arch Gen Psychiatry 1991;48:1082-8.
64. Faedda GL, Tondo L, Baldessarini RJ, Suppes T, Tohen M. Outcome after rapid vs gradual discontinuation of lithium treatment in bipolar disorders. Arch Gen Psychiatry 1993;50:448-55.
65. Gelenberg AJ, Kane JN, Keller MB, Lavori P, Rosenbaum JF, Cole K, Lavelle J. Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorders. N Engl J Med 1989;321:1489-93.
66. Sachs GS, Renshaw PF, Lafer B, Stoll AL, Guimaraes AR, Rosenbaum JF, Gonzales RG. Variability of brain lithium levels during maintenance treatment: a magnetic resonance spectroscopy study. Biol Psychiatry 1995;38:422-8.
67. Plenge P, Stensgaard A, Jensen HV, Thomsen C, Mellerup ET, Henriksen O. 24-hour lithium concentration in human brain studied by Li-7 magnetic resonance spectroscopy. Biol Psychiatry 1994;36:511-6.
68. Greenspan K, Goodwin FK, Bunney WE, J. D. Lithium ion retention and distribution. Patterns during acute mania and normothymia. Arch Gen Psychiatry 1968;19:664-73.
69. Kukopulos A, Minnai G, Muller-Oerlinghausen B. The influence of mania and depression on the pharmacokinetics of lithium. J Affect Disord 1985;8:159-66.
70. Kato T, Takahashi S, Inubushi T. Brain lithium concentration by 7Li- and 1H-magnetic resonance spectroscopy in bipolar disorder. Psychiatry Res 1992;45:53-63.
71. Kato T, Takahashi S, Inhbushi T. Brain lithium concentration measured with lithium-7 magnetic resonance spectroscopy: a review. Lithium 1994;5:75-81.
72. Wilder BJ, Karas BJ, Penry JK, Asconape J. Gastrointestinal tolerance of divalproex sodium. Neurology 1983;33:808-11.
73. 2-receptor antagonists for the treatment of valproate-induced gastrointestinal distress. Ann Clin Psychiatry 1991;3:301-4.
74. Keck PE Jr, McElroy SL, Tugrul KC, Bennett JA. Valproate oral loading in the treatment of acute mania. J Clin Psychiatry 1993;54:305-8.
75. Hansten PD, Horn JR. Inhibition of oral contraceptive efficacy. Drug Interaction Newslett 1985;5:7-10.
76. Cloyd J. Antiepileptic drug interactions: mechanisms and clinical implications. In: Pellock J, ed. Antiepileptic drugs: drug interactions and adverse effects. Deerfield, IL: Discovery International, 1995:42-51.
77. Steekler TL. Lithium and carbamazepine-associated sinus node dysfunction: nine-year experience in a psychiatric hospital. J Clin Psychopharmacol 1994;14:336-9.
78. Parmelee DX, O'Shanick GJ. Carbamazepine-lithium toxicity in brain-damaged adolescents. Brain Injury 1988;2:305-8.
79. Sachs GS. Adjuncts and alternatives to lithium therapy for bipolar affective disorder. J Clin Psychiatry 1989;50[suppl]:31-9.
80. Sachs GS. Use of clonazepam for bipolar affective disorder. J Clin Psychiatry 1990;51[suppl]:31-4.
81. Aronson TA, Shukla S, Hirschowitz J. Clonazepam treatment of five lithium-refractory patients with bipolar disorder. Am J Psychiatry 1989;146:77-80.
82. Bradwejn J, Shriqui C, Koszycki D, Meterissian G. Double-blind comparison of the effect of clonazepam and lorazepam in acute mania. J Clin Psychopharmacol 1990;10:403-8.
83. Reich T, Winokur G. Postpartum psychosis in patients with manic depressive disease. J Nerv Ment Dis 1970;151:60-8.
84. Fabro SE. Clinical obstetrics. New York: John Wiley and Sons, 1987.
85. Lindout D, Schmidt D. In utero exposure to valproate and neural tube defects [letter]. Lancet 1986;1:1392-3.
86. Weinstein MR. The international register of lithium babies. Drug Information J 1976;50:81-6.
87. Cohen LS, Friedman JM, Jefferson JW, Johnson EM, Weiner ML. A reevaluation of risk of in utero exposure to lithium. JAMA 1994;271:146-50.